Moderna, Inc. financials
Key figures from Moderna, Inc.'s filings with the U.S. Securities and Exchange Commission: the latest quarter against a year earlier, and the trend across recent quarters and fiscal years.
Latest quarter vs a year earlier
| Metric | Jun 2026 | Jun 2025 | Change |
|---|---|---|---|
| Revenue | $145M | $142M | +2.1% |
| Net income | -$782M | -$825M | +5.2% |
| Free cash flow | -$563M | -$922M | +38.9% |
| Gross margin | 35.9% | 16.2% | +19.7 pts |
| Operating margin | -562.1% | -638.7% | +76.7 pts |
| Net margin | -539.3% | -581.0% | +41.7 pts |
Quarterly trend
Fiscal years
| Fiscal year | Revenue | Net income | Net margin | Free cash flow | EPS (diluted) |
|---|---|---|---|---|---|
| FY Dec 2025 | $1.9B | -$2.8B | -145.2% | -$2.1B | -$7.26 |
| FY Dec 2024 | $3.2B | -$3.6B | -110.0% | -$4.1B | -$9.28 |
| FY Dec 2023 | $6.8B | -$4.7B | -68.8% | -$3.8B | -$12.33 |
| FY Dec 2022 | $19.3B | $8.4B | 43.4% | $4.6B | $20.12 |
| FY Dec 2021 | $18.5B | $12.2B | 66.1% | $13.3B | $28.29 |
* Fiscal fourth quarter computed from the annual filing minus the three reported quarters. All figures from company filings with the SEC.